AI assistant
INSMED Inc — Director's Dealing 2023
May 17, 2023
30150_dirs_2023-05-17_40d46ed8-2caf-45d1-b5b2-a6ef97fc905d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: INSMED Inc (INSM)
CIK: 0001104506
Period of Report: 2023-05-15
Reporting Person: Smith Michael Alexander (General Counsel, Senior VP)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-05-15 | Common Stock | S | 1897 | $19.24 | Disposed | 78820 | Direct |
| 2023-05-16 | Common Stock | S | 475 | $18.43 | Disposed | 78345 | Direct |
| 2023-05-17 | Common Stock | S | 1263 | $18.18 | Disposed | 77082 | Direct |
Footnotes
F1: Shares sold to satisfy withholding tax obligations upon the vesting of Restricted Stock Units and to cover related broker fees.
F2: This is the weighted average sales price representing 1,897 shares sold at prices ranging from $19.24 to $19.26 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
F3: This is the weighted average sales price representing 475 shares sold at prices ranging from $18.40 to $18.45 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.